We are live on
!
Find out more
GC
Globeflex Capital Portfolio holdings
AUM
$661M
1-Year Est. Return
50.59%
This Fund
S&P 500
This Quarter
Est. Return
+7.43%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$557M
AUM Growth
+$8.06M
(+1.5%)
Cap. Flow
-$17.4M
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
15.98%
Holding
514
New
65
Increased
139
Reduced
63
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ovid Therapeutics
OVID
|
+$3.98M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$2.56M |
| 3 |
SIGA Technologies
SIGA
|
+$2.52M |
| 4 |
Information Services Group
III
|
+$1.69M |
| 5 |
RVI
Retail Value Inc. Common Shares
RVI
|
+$1.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACH
Accendra Health
ACH
|
+$5.72M |
| 2 |
UCTT
Ultra Clean Holdings
UCTT
|
+$2.82M |
| 3 |
Mitek Systems
MITK
|
+$2.11M |
| 4 |
Builders FirstSource
BLDR
|
+$2.1M |
| 5 |
Medpace
MEDP
|
+$2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.86% |
| 2 | Industrials | 16.1% |
| 3 | Technology | 15.87% |
| 4 | Financials | 14.48% |
| 5 | Consumer Discretionary | 11.84% |
Similar funds
RCG
FM
ACM
UCMOK
DC
FAM
CAM
AWA
Globeflex Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Globeflex Capital held 514 positions worth $557M, up 1.5% from $549M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Globeflex Capital withdrew a net $17.4M in Q2 2021, closing 62 positions and reducing 63 holdings. Its most notable exit was Perficient Inc, an estimated $1.89M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.
Against the trend, Globeflex Capital opened a new position in Ovid Therapeutics worth $3.95M.
- Globeflex Capital's largest Q2 2021 buy was Ovid Therapeutics: 1,009,125 shares worth $3.95M.
- Globeflex Capital added most to Amneal Pharmaceuticals in Q2 2021, an estimated $2.56M increase.
- Globeflex Capital's biggest Q2 2021 reduction was Accendra Health, cutting an estimated $5.72M.
- Globeflex Capital fully exited Perficient Inc in Q2 2021, selling an estimated $1.89M.
- Globeflex Capital's ten largest holdings make up 16% of its $557M portfolio in Q2 2021.
- Globeflex Capital opened 65 new positions and closed 62 in Q2 2021.
- Globeflex Capital's portfolio value rose 1.5% quarter-over-quarter to $557M.
Based on Globeflex Capital's 13F filing for Q2 2021, filed 12 Aug 2021.